Technical Analysis for NARI - Inari Medical, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Multiple of Ten Bearish | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Multiple of Ten Bearish | Other | -2.33% | |
| Wide Bands | Range Expansion | -2.33% | |
| Multiple of Ten Bullish | Other | -3.10% | |
| Wide Bands | Range Expansion | -3.10% | |
| Gapped Down | Weakness | -3.10% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -8.02% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 5% | about 18 hours ago |
| 60 Minute Opening Range Breakdown | about 18 hours ago |
| 10 DMA Support | about 18 hours ago |
| Down 3% | about 18 hours ago |
| Fell Below Previous Day's Low | about 18 hours ago |
Get a Trading Assistant
- Earnings date: 05/09/2022
Inari Medical, Inc. Description
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Disease Catheter FDA Hematology Quality Of Life Veins Angiology Thrombosis Blood Clots Deep Vein Thrombosis Embolectomy Pulmonary Embolism Thrombectomy Thrombus Venous Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 100.0 |
| 52 Week Low | 50.5014 |
| Average Volume | 808,489 |
| 200-Day Moving Average | 81.90 |
| 50-Day Moving Average | 79.47 |
| 20-Day Moving Average | 67.85 |
| 10-Day Moving Average | 57.56 |
| Average True Range | 5.67 |
| RSI | 36.31 |
| ADX | 26.03 |
| +DI | 16.94 |
| -DI | 32.82 |
| Chandelier Exit (Long, 3 ATRs) | 77.77 |
| Chandelier Exit (Short, 3 ATRs) | 67.52 |
| Upper Bollinger Bands | 91.00 |
| Lower Bollinger Band | 44.71 |
| Percent B (%b) | 0.29 |
| BandWidth | 68.23 |
| MACD Line | -7.04 |
| MACD Signal Line | -6.87 |
| MACD Histogram | -0.1713 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 67.32 | ||||
| Resistance 3 (R3) | 67.36 | 64.38 | 65.81 | ||
| Resistance 2 (R2) | 64.38 | 62.06 | 64.36 | 65.30 | |
| Resistance 1 (R1) | 61.30 | 60.63 | 59.81 | 61.26 | 64.79 |
| Pivot Point | 58.32 | 58.32 | 57.57 | 58.30 | 58.32 |
| Support 1 (S1) | 55.24 | 56.00 | 53.75 | 55.20 | 51.67 |
| Support 2 (S2) | 52.26 | 54.57 | 52.24 | 51.16 | |
| Support 3 (S3) | 49.18 | 52.26 | 50.66 | ||
| Support 4 (S4) | 49.14 |
